POAI - Predictive Oncology Inc.
1.11
-0.230 -20.721%
Share volume: 465,053
Last Updated: 04-07-2025
Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies:
-0.01%
PREVIOUS CLOSE
CHG
CHG%
$1.34
-0.23
-0.17%
Fundamental analysis
20%
Profitability
0%
Dept financing
20%
Liquidity
53%
Performance
32%
Performance
5 Days
-18.98%
1 Month
3.74%
3 Months
-17.16%
6 Months
72.07%
1 Year
-41.88%
2 Year
-80.11%
Key data
Stock price
$1.11
DAY RANGE
$1.10 - $1.34
52 WEEK RANGE
$0.55 - $3.06
52 WEEK CHANGE
-$36.93
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
05-13-2025
Company detail
CEO: Raymond F. Vennare
Region: US
Website: predictive-oncology.com
Employees: 30
IPO year: 2013
Issue type: Common Stock
Market: XNAS
Industry: Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies
Sector: Manufacturing
Region: US
Website: predictive-oncology.com
Employees: 30
IPO year: 2013
Issue type: Common Stock
Market: XNAS
Industry: Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies
Sector: Manufacturing
Predictive Oncology Inc. focuses on developing personalized cancer therapies using artificial intelligence (AI) The company operates in four segments: Helomics, zPREDICTA, Soluble, and Skyline. It also offers research and development services; and media that help cancer cells grow outside the patient's body and retain their DNA/RNA and proteomic signatures.
Recent news
